Article    Table of Contents                    Full Text of this article Free    Figures/Tables List  Services    Send comment/rapid response letter    Notify a friend about this article    Alert me when this article is cited    Add to Personal Archive    Download to Citation Manager    ACP Search                            Get Permissions  Google Scholar    Search for Related Content  PubMed Articles in PubMed by Author:    Janes, C. H.    Lindor, K. D.    Related Articles in PubMed    PubMed Citation    PubMed

ARTICLE

Outcome of Patients Hospitalized for Complications after Outpatient Liver Biopsy

Christine H. Janes and Keith D. Lindor

15 January 1993 | Volume 118 Issue 2 | Pages 96-98

Objective: To determine the safety of outpatient liver biopsies by analyzing the outcome of patients hospitalized for complications.

Design: Retrospective review.

Setting: Large clinic referral center.

Patients: All patients admitted after outpatient liver biopsy at the Mayo Clinic from 1 April 1989 to 1 April 1991.

Results: During this period, 405 outpatients underwent biopsy. Of the 405 patients, 13 (3.2%) were admitted with complications after biopsy. Five patients (38%) were admitted with persistent localized pain, five (38%) with orthostatic hypotension, one (8%) with both pain and hypotension, one (8%) with peritoneal signs, and one (8%) with lightheadedness but no orthostatic changes. All complications were noted within 3 hours after the biopsy. Bleeding, potentially the most serious complication, was radiographically defined in 5 of the 13 patients (38%) admitted. Only two patients, however, required blood transfusions. No patient required invasive management such as surgery or chest tube placement. The average length of the hospital stay was 1.5 days.

Conclusion: Complications after outpatient liver biopsy occur early and rarely require invasive management. Outpatient liver biopsy is safe when done on carefully selected patients in a setting that provides close observation for at least 3 hours after liver biopsy.

Author and Article Information

From the Mayo Foundation, Rochester, Minnesota.
Requests for Reprints: Keith D. Lindor, MD, Mayo Clinic, 200 First Street SW, Rochester, MN 55905.

This article has been cited by other articles:

				M. Hagiwara, H. Rusinek, V. S. Lee, M. Losada, M. A. Bannan, G. A. Krinsky, and B. Taouli Advanced Liver Fibrosis: Diagnosis with 3D Whole-Liver Perfusion MR Imaging--Initial Experience Radiology, March 1, 2008; 246(3): 926 - 934. [Abstract] [Full Text] [PDF]

				B. Taouli, A. J. Tolia, M. Losada, J. S. Babb, E. S. Chan, M. A. Bannan, and H. Tobias Diffusion-Weighted MRI for Quantification of Liver Fibrosis: Preliminary Experience Am. J. Roentgenol., October 1, 2007; 189(4): 799 - 806. [Abstract] [Full Text] [PDF]

				R. Chou, E. C. Clark, and M. Helfand Screening for Hepatitis C Virus Infection: A Review of the Evidence for the U.S. Preventive Services Task Force Ann Intern Med, March 16, 2004; 140(6): 465 - 479. [Abstract] [Full Text] [PDF]

				A. Giorgio, L. Tarantino, G. de Stefano, G. Francica, F. Esposito, A. Perrotta, V. Aloisio, N. Farella, N. Mariniello, C. Coppola, et al. Complications After Interventional Sonography of Focal Liver Lesions: A 22-Year Single-Center Experience J. Ultrasound Med., February 1, 2003; 22(2): 193 - 205. [Abstract] [Full Text] [PDF]

				A. A. Bravo, S. G. Sheth, and S. Chopra Liver Biopsy N. Engl. J. Med., February 15, 2001; 344(7): 495 - 500. [Full Text] [PDF]

				J. B. Wong, W. G. Bennett, R. S. Koff, and S. G. Pauker Pretreatment Evaluation of Chronic Hepatitis C: Risks, Benefits, and Costs JAMA, December 23, 1998; 280(24): 2088 - 2093. [Abstract] [Full Text] [PDF]

				Outpatient Liver Biopsy Is Safe in Selected Patients Journal Watch Dermatology, March 1, 1993; 1993(301): 13 - 13. [Full Text]

				OUTPATIENT LIVER BIOPSY IS SAFE IN SELECTED PATIENTS Journal Watch (General), January 26, 1993; 1993(126): 4 - 4. [Full Text]